NCT06250244 2024-12-11
177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital
Phase 1/2 Unknown
Clinical Trials
885 trialsNCT05644821 2024-10-01
PRO-P
Heinrich-Heine University, Duesseldorf
Phase NA Unknown
NCT03362801 2024-07-19
SAMPHYR
University Hospital, Caen
Phase NA Unknown
NCT05155618 2024-06-18
MicroStyle
European Institute of Oncology
Phase NA Unknown
NCT05899751 2024-05-10
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Unknown
NCT05710159 2024-03-01
iBLAD-app
Odense University Hospital
Unknown
NCT06288802 2024-03-01
Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital
South Egypt Cancer Institute
Unknown
NCT05946161 2024-02-29
Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual Health
Universidade do Porto
Phase NA Unknown
NCT04641078 2024-02-28
DART
University Hospital, Ghent
Phase 2 Unknown
NCT05627752 2024-02-28
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Zhongnan Hospital
Phase 2/3 Unknown
NCT06274684 2024-02-28
Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.
University Hospital, Geneva
Phase NA Unknown
NCT06282354 2024-02-28
Telemedicine for Postoperative Follow-up After Oncological Surgeries
Instituto do Cancer do Estado de São Paulo
Unknown
NCT06258486 2024-02-26
Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks
Kaiser Permanente
Phase 4 Unknown
NCT05279287 2024-02-22
VAMIS
The Griffin Institute
Unknown
NCT04416646 2024-02-21
ZEBRA
Istituto Oncologico Veneto IRCCS
Unknown
NCT06251492 2024-02-20
Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)
Fudan University
Phase 2 Unknown
NCT06253091 2024-02-20
Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT03924466 2024-02-16
VUBAR
Universitair Ziekenhuis Brussel
Phase 2 Unknown
NCT06148220 2024-02-16
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
Huashan Hospital
Phase NA Unknown
NCT05612204 2024-02-14
BIOPROSTATIRM
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase NA Unknown
NCT05626101 2024-02-13
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
Al-Azhar University
Phase NA Unknown
NCT05829057 2024-02-13
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Phase 1 Unknown
NCT04262609 2024-02-08
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
Consorci Sanitari de Terrassa
Unknown
NCT03899077 2024-02-07
SAVE
Cancer Research Antwerp
Phase 2 Unknown
NCT04419402 2024-02-07
ENZA-p
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Unknown
NCT06245759 2024-02-07
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
Huazhong University of Science and Technology
Unknown
NCT05947188 2024-02-05
CMNDPC
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT06242509 2024-02-05
AkkPRO
Assistance Publique - Hôpitaux de Paris
Unknown
NCT04599218 2024-02-02
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
Northwell Health
Phase NA Unknown
NCT04656678 2024-02-02
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer
Northwell Health
Phase NA Unknown
NCT05567588 2024-02-01
Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT05452824 2024-01-30
PEAK-RP
AHS Cancer Control Alberta
Phase NA Unknown
NCT04693169 2024-01-25
[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT04967001 2024-01-25
68Ga-PSMA PET in the Prostate Cancer
Xijing Hospital
Phase NA Unknown
NCT06201741 2024-01-25
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer
Huashan Hospital
Phase NA Unknown
NCT01864096 2024-01-24
MAST
University Health Network, Toronto
Phase 3 Unknown
NCT03432949 2024-01-24
TRANCE
University Health Network, Toronto
Phase 4 Unknown
NCT04081246 2024-01-23
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
Chinese University of Hong Kong
Phase NA Unknown
NCT06204614 2024-01-12
Drug Screening Using IMD in Bladder Cancer
Brigham and Women's Hospital
Phase EARLY_PHASE1 Unknown
NCT05584787 2024-01-10
Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis
San Carlo di Nancy Hospital
Phase NA Unknown
NCT05161728 2024-01-09
PET-MaN
UMC Utrecht
Phase NA Unknown
NCT05539300 2024-01-09
PET-MaN-enza
UMC Utrecht
Phase NA Unknown
NCT06152419 2024-01-05
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
Phase NA Unknown
NCT06133699 2024-01-03
PITERLAND
N.N. Petrov National Medical Research Center of Oncology
Phase NA Unknown
NCT06144099 2024-01-02
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery
Konkuk University Medical Center
Phase 4 Unknown
NCT06183905 2023-12-28
TRUSVSMPMRI
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Unknown
NCT06182735 2023-12-27
CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma
Fudan University
Phase 1 Unknown
NCT02473003 2023-12-21
Phys-Can
Uppsala University
Phase NA Unknown
NCT02138721 2023-12-20
LoMP
University Hospital, Ghent
Phase NA Unknown
NCT05150236 2023-12-15
ANZUP2001
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Unknown